Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Doctor's Choices Influenced by Lab Test Cost

By LabMedica International staff writers
Posted on 23 Apr 2013
When doctors know what hospitals charge for certain lab tests, they order far fewer of them or look for cheaper alternatives. More...


Investigators discovered that currently hospitals generally do not disclose the price of lab tests to doctors and this contributes to the high cost of health care in the US.

A six-month study looked at the use of 62 diagnostic blood tests frequently ordered for patients at the Johns Hopkins Hospital (Baltimore, MD, USA) Doctors in one group were given the cost of each of the tests while doctors in another group were not provided with that information.

The group of doctors who knew the prices ordered nearly 9% fewer lab tests, which saved more than USD 400,000 over the study period, according to the study appearing April 15, 2013, in the journal JAMA Internal Medicine. There was a 6% increase in the number of tests ordered by the group of doctors who did not know the prices.

"We generally don't make decisions based on what is cost-effective or what is known to be absolutely necessary for our patients, but knowing the cost of things appears to make us more thoughtful about what we think might be best for their health," study leader Dr. Leonard Feldman, an assistant professor of medicine at Johns Hopkins, said in a hospital news release. He added, "There's a lot of waste in medicine because we don't have a sense of the costs of much of what we do."

Feldman said the findings offer "evidence that presenting providers with associated test fees as they order is a simple and unobtrusive way to alter behavior. In the end, we ordered fewer tests, saved money, and saved patients from extra needle sticks without any negative outcomes."

Many of the savings seen in the study were the result of comparison-shopping. For example, it cost USD 15.44 for a comprehensive metabolic panel, a blood test that checks fluid and electrolyte status, kidney and liver function, blood sugar levels, and response to various medications. A basic metabolic panel checks many of the same things but costs USD 3.08.

During the six-month study, the number of comprehensive metabolic panel tests ordered by doctors who knew the price fell by about 8,900, while the number of basic metabolic panels grew by about the same number. That shift alone saved more than USD 27,000 over the study period, the scientists said.

Related Links:

Johns Hopkins Hospital



Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.